ID

38945

Descrizione

Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations; ODM derived from: https://clinicaltrials.gov/show/NCT01680328

collegamento

https://clinicaltrials.gov/show/NCT01680328

Keywords

versioni (1)
  1. 14/11/19 14/11/19 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

14 novembre 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Diabetes NCT01680328

Inglese

Eligibility Diabetes NCT01680328

1 moduli  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01680328
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
informed consent obtained before any trial-related activities.
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
type 1 or type 2 diabetes
Descrizione

Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus, Non-Insulin-Dependent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011854
UMLS CUI [2]
C0011860
daily injection(s) with anti-diabetic drug (insulin or glucagon like peptide-1 (glp-1) analogues) via pen-injector or vial/syringe for more than 6 months
Descrizione

Antidiabetics Injection Daily | Insulin | GLP-1 Analogue | Injection via Pen Injector | Injection via Vial | Injection via Syringe

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1533685
UMLS CUI [1,3]
C0332173
UMLS CUI [2]
C0021641
UMLS CUI [3]
C3273809
UMLS CUI [4,1]
C1533685
UMLS CUI [4,2]
C1550513
UMLS CUI [4,3]
C4025916
UMLS CUI [5,1]
C1533685
UMLS CUI [5,2]
C1550513
UMLS CUI [5,3]
C0184301
UMLS CUI [6,1]
C1533685
UMLS CUI [6,2]
C1550513
UMLS CUI [6,3]
C0039142
body mass index (bmi) between 18.5 and 30.0 kg/m^2 (both included)
Descrizione

Body mass index

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1305855
caucasians
Descrizione

Caucasians

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0043157
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
known or suspected hypersensitivity to needle, ink ball pen or other that are in contact with the injection area during the clinical visit
Descrizione

Hypersensitivity Needle | Other Coding

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0027551
UMLS CUI [2]
C3846158
previous participation in this trial. participation is defined as: screened
Descrizione

Study Subject Participation Status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
receipt of any investigational medicinal product that can influence pain perception within 14 days before screening
Descrizione

Investigational New Drugs Influence Pain Perception

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C4054723
UMLS CUI [1,3]
C3714605
injection of more than 40 units of insulin per injection
Descrizione

Injection Insulin Unit Quantity

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1533685
UMLS CUI [1,2]
C0021641
UMLS CUI [1,3]
C0869039
UMLS CUI [1,4]
C1265611
continuous subcutaneous insulin infusion use within the last 6 months
Descrizione

Continuous subcutaneous infusion of insulin

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0393124
continuous glucose monitoring use within the last 6 months
Descrizione

Continuous glucose monitoring

Tipo di dati

boolean

Alias
UMLS CUI [1]
C4523945
intake of any pain-relieving or analgesic within the last week (excluding low dose aspirin in cardio vascular prophylactic doses)
Descrizione

Administration of analgesic | Exception Aspirin Low Dose

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0262176
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C2608320
known active or in-active skin disease in the injection area or that may affect pain perception
Descrizione

Dermatologic disorder Injection Area | Dermatologic disorder Affecting Pain Perception

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0037274
UMLS CUI [1,2]
C1533685
UMLS CUI [1,3]
C0205146
UMLS CUI [2,1]
C0037274
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C3714605
anti-coagulant treatment within the last month (low dose of aspirin in cardiovascular prophylactic doses is allowed. however, not on the day of the injections)
Descrizione

Anticoagulant therapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0150457
Ritorna all'inizio della pagina

Similar models

Eligibility Diabetes NCT01680328

1 moduli
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01680328
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
informed consent obtained before any trial-related activities.
boolean
C0021430 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus, Non-Insulin-Dependent
Item
type 1 or type 2 diabetes
boolean
C0011854 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
Antidiabetics Injection Daily | Insulin | GLP-1 Analogue | Injection via Pen Injector | Injection via Vial | Injection via Syringe
Item
daily injection(s) with anti-diabetic drug (insulin or glucagon like peptide-1 (glp-1) analogues) via pen-injector or vial/syringe for more than 6 months
boolean
C0935929 (UMLS CUI [1,1])
C1533685 (UMLS CUI [1,2])
C0332173 (UMLS CUI [1,3])
C0021641 (UMLS CUI [2])
C3273809 (UMLS CUI [3])
C1533685 (UMLS CUI [4,1])
C1550513 (UMLS CUI [4,2])
C4025916 (UMLS CUI [4,3])
C1533685 (UMLS CUI [5,1])
C1550513 (UMLS CUI [5,2])
C0184301 (UMLS CUI [5,3])
C1533685 (UMLS CUI [6,1])
C1550513 (UMLS CUI [6,2])
C0039142 (UMLS CUI [6,3])
Body mass index
Item
body mass index (bmi) between 18.5 and 30.0 kg/m^2 (both included)
boolean
C1305855 (UMLS CUI [1])
Caucasians
Item
caucasians
boolean
C0043157 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Hypersensitivity Needle | Other Coding
Item
known or suspected hypersensitivity to needle, ink ball pen or other that are in contact with the injection area during the clinical visit
boolean
C0020517 (UMLS CUI [1,1])
C0027551 (UMLS CUI [1,2])
C3846158 (UMLS CUI [2])
Study Subject Participation Status
Item
previous participation in this trial. participation is defined as: screened
boolean
C2348568 (UMLS CUI [1])
Investigational New Drugs Influence Pain Perception
Item
receipt of any investigational medicinal product that can influence pain perception within 14 days before screening
boolean
C0013230 (UMLS CUI [1,1])
C4054723 (UMLS CUI [1,2])
C3714605 (UMLS CUI [1,3])
Injection Insulin Unit Quantity
Item
injection of more than 40 units of insulin per injection
boolean
C1533685 (UMLS CUI [1,1])
C0021641 (UMLS CUI [1,2])
C0869039 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
Continuous subcutaneous infusion of insulin
Item
continuous subcutaneous insulin infusion use within the last 6 months
boolean
C0393124 (UMLS CUI [1])
Continuous glucose monitoring
Item
continuous glucose monitoring use within the last 6 months
boolean
C4523945 (UMLS CUI [1])
Administration of analgesic | Exception Aspirin Low Dose
Item
intake of any pain-relieving or analgesic within the last week (excluding low dose aspirin in cardio vascular prophylactic doses)
boolean
C0262176 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C2608320 (UMLS CUI [2,2])
Dermatologic disorder Injection Area | Dermatologic disorder Affecting Pain Perception
Item
known active or in-active skin disease in the injection area or that may affect pain perception
boolean
C0037274 (UMLS CUI [1,1])
C1533685 (UMLS CUI [1,2])
C0205146 (UMLS CUI [1,3])
C0037274 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C3714605 (UMLS CUI [2,3])
Anticoagulant therapy
Item
anti-coagulant treatment within the last month (low dose of aspirin in cardiovascular prophylactic doses is allowed. however, not on the day of the injections)
boolean
C0150457 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial